| 5-hydroxytryptamine (serotonin) receptor 2A |
DOXAZOSIN |
Serotonin 5-HT2A |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
DIPHENHYDRAMINE |
Adrenergic alpha1A |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
HALOPROGIN |
Melanocortin MC3 |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
HALOPROGIN |
Melanocortin MC3 |
34% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
NOVARTIS P-38 INHIBITOR |
Acetylcholinesterase |
34% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
NOVARTIS P-38 INHIBITOR |
Acetylcholinesterase |
34% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
NOVARTIS P-38 INHIBITOR |
Acetylcholinesterase |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NORGESTREL |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
NORFLOXACIN |
Sigma2 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
RITONAVIR |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
RITONAVIR |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
RITONAVIR |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
RITONAVIR |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| angiotensin II receptor, type 2 |
SAQUINAVIR |
Angiotensin AT2 |
34% |
NoneNone |
NoneNone |
View
|
| epidermal growth factor receptor |
RESERPINE |
Protein Tyrosine Kinase, EGF Receptor |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
PANTHENOL |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
PANTHENOL |
Leukotriene C4 Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
TRETINOIN |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
TRETINOIN |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
TRETINOIN |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
TRETINOIN |
Sodium Channel, Site 2 |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
TROPICAMIDE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
TROPICAMIDE |
Thromboxane Synthetase |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
THALIDOMIDE |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
THALIDOMIDE |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
CIMETIDINE |
Adrenergic alpha2B |
34% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
TROVAFLOXACIN |
Muscarinic M5 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
TRIMETHADIONE |
Serotonin 5-HT1A |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
TEMAFLOXACIN |
Adrenergic alpha2B |
34% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
TEMAFLOXACIN |
Muscarinic M1 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 1 |
TERBUTALINE |
Adrenergic beta1 |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic, beta-1-, receptor |
TERBUTALINE |
Adrenergic beta1 |
34% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
CILOSTAMIDE |
Histamine H2 |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
ERGONOVINE |
CYP450-2D6 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
DICYCLOMINE |
Platelet Activating Factor (PAF) |
34% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
NIFEDIPINE |
Aldose Reductase |
34% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
NIFEDIPINE |
Aldose Reductase |
34% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
NIFEDIPINE |
Aldose Reductase |
34% |
NoneNone |
NoneNone |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
NIFEDIPINE |
Aldose Reductase |
34% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, alpha polypeptide |
CYTARABINE |
Platelet-Derived Growth Factor (PDGF) |
34% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, alpha polypeptide |
CYTARABINE |
Platelet-Derived Growth Factor (PDGF) |
34% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, beta polypeptide |
CYTARABINE |
Platelet-Derived Growth Factor (PDGF) |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MESTRANOL |
Calcium Channel Type L, Benzothiazepine |
34% |
NoneNone |
NoneNone |
View
|
| adenosine A1 receptor |
4-OCTYLPHENOL |
Adenosine A1 |
34% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
MC 258714 |
CYP450-2D6 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
BISPHENOL A |
Opiate delta |
34% |
NoneNone |
NoneNone |
View
|
| opioid receptor, kappa 1 |
BETA-ESTRADIOL 3-BENZOATE |
Opiate kappa |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BISPHENOL A |
Calcium Channel Type L, Phenylalkylamine |
34% |
NoneNone |
NoneNone |
View
|
| melanocortin 4 receptor |
PRAZIQUANTEL |
Melanocortin MC4 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
PINDOLOL |
Cyclooxygenase COX-1 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PINDOLOL |
Cyclooxygenase COX-1 |
34% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
CHOLECALCIFEROL |
CYP450-3A4 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
LISINOPRIL |
CYP450-3A4 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 5 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 3 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
PRAZOSIN |
Potassium Channel HERG |
34% |
24.2778uM |
19.8902uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
GERANIOL |
CYP450-3A4 Inhibition |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Cyclooxygenase COX-2 |
34% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3, catalytic subunit, beta isoform |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
PERHEXILINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
34% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 2 |
SULOCTIDIL |
Adrenergic beta2 |
34% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
HYDROXYCHLOROQUINE |
Sigma2 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
DOMPERIDONE |
Serotonin 5-HT6 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
DIMENHYDRINATE |
Serotonin 5-HT4 |
34% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
DIMENHYDRINATE |
Serotonin 5-HT4 |
34% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
MONTELUKAST |
Purinergic P2X |
34% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
MONTELUKAST |
Purinergic P2X |
34% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
MONTELUKAST |
Purinergic P2X |
34% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
CHROMIUM(III) CHLORIDE |
Protein Tyrosine Kinase, Lck |
34% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
HYDROXYPROGESTERONE |
Protein Serine/Threonine Kinase PKCalpha |
34% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
HYDROXYPROGESTERONE |
Protein Serine/Threonine Kinase PKCalpha |
34% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
4-NONYLPHENOL |
Opiate delta |
34% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
HYDROXYPROGESTERONE |
Muscarinic M1 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
ZAFIRLUKAST |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
ZAFIRLUKAST |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
ZAFIRLUKAST |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
ZAFIRLUKAST |
Leukotriene B4 |
34% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
IODOQUINOL |
Glutamate, NMDA, Agonism |
34% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
SULPIRIDE |
Dopamine D4.2 |
34% |
NoneNone |
NoneNone |
View
|
| dopamine receptor 2 |
CYCLIZINE |
Dopamine D2L |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
4-NONYLPHENOL |
Calcium Channel Type L, Dihydropyridine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
4-NONYLPHENOL |
Calcium Channel Type L, Dihydropyridine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
4-NONYLPHENOL |
Calcium Channel Type L, Dihydropyridine |
34% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
4-NONYLPHENOL |
Calcium Channel Type L, Dihydropyridine |
34% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
RAPAMYCIN |
GABAA, Chloride Channel, TBOB |
35% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
TIRILAZAD |
Adenosine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
TIRILAZAD |
Adenosine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
TIRILAZAD |
Adenosine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
TIRILAZAD |
Adenosine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
TIRILAZAD |
Adenosine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
CERIVASTATIN |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
CERIVASTATIN |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
CELECOXIB |
Serotonin 5-HT6 |
35% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
DOXORUBICIN |
Adrenergic alpha1A |
35% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
3-METHYLCHOLANTHRENE |
Endothelin ETA |
35% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
AMITRIPTYLINE |
Melanocortin MC5 |
35% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
CHLORAMPHENICOL |
CYP450-2C19 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
AMIODARONE |
ATPase, Na+/K+ |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
1-AMINOBENZOTRIAZOLE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
1-AMINOBENZOTRIAZOLE |
Cyclooxygenase COX-2 |
35% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
AMRINONE |
Adrenergic, Norepinephrine Transporter |
35% |
NoneNone |
NoneNone |
View
|
| caspase 1 |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| caspase 3, apoptosis related cysteine protease |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| caspase 2 |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| caspase 7 |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| caspase 6 |
TRIMETHADIONE |
Protease, Caspase 1 |
35% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
CIMETIDINE |
Neuropeptide Y1 |
35% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
PERGOLIDE |
Sigma1 |
35% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
LOMUSTINE |
Adrenergic alpha2A |
35% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| protein phosphatase 3, catalytic subunit, beta isoform |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
ECONAZOLE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
35% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
METHOXSALEN |
CYP450-2D6 Inhibition |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 5a, mitochondrial |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 3 |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 2 |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase 4 |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase XI |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| carbonic anhydrase IX |
BENZO[A]PYRENE |
Carbonic Anhydrase |
35% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
CYPROTERONE ACETATE |
Opiate delta |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
RITONAVIR |
GABAA, Chloride Channel, TBOB |
34% |
NoneNone |
NoneNone |
View
|